Yuan Xu

CIK: 0001858214

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

FATE

FATE THERAPEUTICS INC

Director

XLO

Xilio Therapeutics, Inc.

Director

AKRO

Akero Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

FATE
FATE THERAPEUTICS INC
Jun 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
87.9K shares-
XLO
Xilio Therapeutics, Inc.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
5K shares-
AKRO
Akero Therapeutics, Inc.
Dec 9, 2025
Disposition(D)
Direct
9.4K shares-
XLO
Xilio Therapeutics, Inc.
Jun 11, 2025
Award(A)
Stock Option (right to buy)
Direct
31K shares-
AKRO
Akero Therapeutics, Inc.
Jun 3, 2025
Award(A)
Direct
9.4K shares-
FATE
FATE THERAPEUTICS INC
May 29, 2025
Award(A)
Stock Option (Right to Buy)
Direct
55K shares-

		Type	Shares	Price		Ownership
Jun 12, 2026	FATE FATE THERAPEUTICS INC	Award(A) Stock Option (Right to Buy)	87,900	-	-	Direct
Jun 11, 2026	XLO Xilio Therapeutics, Inc.	Award(A) Stock Option (right to buy)	5,000	-	-	Direct
Dec 9, 2025	AKRO Akero Therapeutics, Inc.	Disposition(D)	9,398	-	-	Direct
Jun 11, 2025	XLO Xilio Therapeutics, Inc.	Award(A) Stock Option (right to buy)	31,000	-	-	Direct
Jun 3, 2025	AKRO Akero Therapeutics, Inc.	Award(A)	9,398	-	-	Direct
May 29, 2025	FATE FATE THERAPEUTICS INC	Award(A) Stock Option (Right to Buy)	55,000	-	-	Direct

1-6 of 6 transactions

About Xu Yuan

Xu Yuan (SEC CIK 0001858214) files insider reports with the SEC as Director of FATE THERAPEUTICS INC (FATE), Director of Xilio Therapeutics, Inc. (XLO) and Director of Akero Therapeutics, Inc. (AKRO).

Signal8 holds 6 ownership filings by Xu Yuan, all Form 4s, filed between May 30, 2025 and Jun 15, 2026. Those filings report 6 transactions, from May 29, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Xu Yuan's filings is in WALTHAM, MA.

Recent filings by Xu Yuan

Jun 12, 2026: Grant or award of FATE derivative securities (Form 4, code A).
Jun 11, 2026: Grant or award of XLO derivative securities (Form 4, code A).
Dec 9, 2025: Disposition to issuer transaction of AKRO shares (Form 4, code D).
Jun 11, 2025: Grant or award of XLO derivative securities (Form 4, code A).
Jun 3, 2025: Grant or award of AKRO shares (Form 4, code A).

Other insiders filing for FATE THERAPEUTICS INC (FATE)

TAHL CINDY
Valamehr Bahram, President and CEO
Redmile Group, LLC, Director
Lee Michael Stewart, Director
Jooss Karin, Director
EPSTEIN ROBERT S, Director

How to read Form 4 transaction codes